March 11, 2011 – Recently, refining and recycling companies have questioned whether or not X-ray shredding was required under the HITECH bill. Some companies were mistakenly reporting that shredding was necessary in order to fully destroy the materials. As a result, hospital and healthcare organizations were spending extra money on this service, when it turned out to be unnecessary.

March 11, 2011 – U.S. Food and Drug Administration (FDA) and Lantheus Medical Imaging Inc. today reached agreement on a phase 3 clinical trial design to assess myocardial perfusion using flurpiridaz F18 positron emission tomography (PET) imaging in patients with suspected or known coronary artery disease (CAD).